Store
COVID-19 Testing Market Update, 2022
Publication Date: April 19, 2022
Tags: COVID-19, Infectious Diseases, Pharmaceuticals, Vaccines
Pages: 65
SKU: 22-026
Gain valuable insights into the evolving COVID-19 testing market with Kalorama Information’s comprehensive report, COVID-19 Testing Market Update, 2022. This report offers detailed market sizing and estimates for various COVID-19 tests and explores the market impacts of the ongoing pandemic. Throughout 2021 and into 2022, the relentless presence of COVID-19 has significantly influenced laboratories and in vitro diagnostic (IVD) companies, with testing expanding from large labs and clinics to home environments, boosting market revenues.
Diagnostics have been crucial in the response to COVID-19, underscoring the need for rapid and accurate testing to manage the pandemic effectively. The report anticipates continued investment in diagnostic systems, driven by the pandemic’s lessons and the importance of testing. The forecasted market analysis through 2027 considers demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology, and global use.
Key Market Data:
- Test Types: The report breaks down market share by test type, including antigen, PCR, antibody, and point-of-care tests.
- Forecasts: While there is some uncertainty in exact forecasting, the report provides estimates and projections for the market through 2027.
Segmentation and Analysis: Our report includes comprehensive segmentation and breakout analysis, highlighting:
- Company Market Share: Competitive analysis of the top ten market participants.
- Trends and Innovations: Examination of market trends, products, and recent test innovations.
- Regional Breakdown: Detailed regional analysis covering North America, Europe, Asia-Pacific, and the Rest of the World.
Market Segmentation by Test Method:
- Immunoassay Antigen Tests: Used for identifying infected individuals and confirming safety for social interactions.
- Molecular PCR Tests: The most sensitive COVID-19 diagnostic tests, recommended by WHO for confirming diagnoses in symptomatic individuals.
- Immunoassay Antibody Tests: Provide information on individual protection through vaccination or previous infection.
Table: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment, 2022-2027 (in millions $)
| Segment | Sales 2022 | % Mkt | Sales 2027 | % Mkt |
| Immunoassay | $XX Million | XX% | $XX Million | XX% |
| Molecular | $XX Million | XX% | $XX Million | XX% |
| Total, Lab-based COVID-19 Market | $XX Million | XX% | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
COVID-19 Testing Market Demand and Growth
- Figure 1-1: COVID Market 2020 vs. 2021, ($billions)
- Figure 1-2: COVID Testing by Quarter 2021, ($millions)
- Figure 1-3: COVID-19 Test Market by Type, Q1-Q4 2021 Trend (Serology, Antigen, Molecular, Rapid) ($millions)
Growth Outlook
- Figure 1-4: Growth Outlook for COVID-19 Testing, 2021 -2023 (percent)
Country Distribution
- Figure 1-5: COVID-19 Revenue by Country, 2021
Test Innovations and Approvals
- Table 1-1: Recent COVID-19 Test Approvals and Innovations
Chapter 2: Trends and Developments
Antigen and Molecular Product Developments
Antigen
Molecular
Other Developments
COVID-19 Testing Expands Multiplex Testing
COVID-19 Drives Molecular Point of Care Growth
AI Mines CT, Lab Results to Predict COVID-19 Severity
Long COVID Can Be Predicted Early On
Spectroscopy Employed in COVID-19
Chapter 3: Market Analysis COVID Testing
Market Analysis: Molecular, Antigen, Antibody and Rapid Tests
Table 3-1: COVID-19 Product Sales by Type — Immunoassay, Molecular, Rapid [at home, professional POC], 2021 ($ millions)
COVID-19 Test Market Share
- Figure 3-1: COVID-19 Testing Market Share, 2021
COVID-19 Test Market by Country
- Table 3-2: COVID-19 Market by Country (India, China, UK, Germany, Spain, Italy, France, Mexico
US, Canada, Japan, Africa / Middle East, Rest of World)
Chapter 4: Top IVD Market Participants
Abbott Laboratories
- Table 4-1: Abbott Corporate Summary
- Figure 4-1: Abbott Diagnostics Revenue by Segment (Core Laboratory, Molecular, Point-of-Care, Rapid Diagnostics, COVID-19, BinaxNOW/ID NOW) Full Year, 2020 and 2021
- Figure 4-2: COVID-19 Distribution of Diagnostic Test Sales, Abbott Laboratories
- Table 4-2: COVID-19 Test Sales, Abbott Laboratories
Becton Dickinson
- Table 4-3: Becton Dickinson Corporate Summary
bioMérieux SA
- Table 4-4: bioMérieux Corporate Summary
- Figure 4-3: bioMérieux Clinical Applications Segment, Full Year Results, 2020,2021
Danaher Corporation
- Table 4-5: Danaher Corporation Summary
Recent Results
- Figure 4-4: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021
Hologic, Inc.
- Table 4-6: Hologic Corporate Summary
Recent Results
- Figure 4-5: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M
Qiagen
- Table 4-7: Qiagen Corporate Summary
Recent Results
- Figure 4-6: QIAGEN Revenue Mix Distribution by Business Segment (Molecular Diagnostics, Life Sciences), Q3 2021
- Figure 4-7: QIAGEN Sales by Product Group (Sample Technologies, Diagnostic Solutions, PCR/Nucleic Acid Amplification, Genomics/NGS, Other), Q3 2021 ($ millions)
Quidel Corporation
- Table 4-8: Quidel Corporate Summary
Recent Results
- Figure 4-8: Quidel Corporation Revenue by Product Group, Full Year Results 2020, 2021, $M
Roche Diagnostics
- Table 4-9: Roche Diagnostic Corporate Summary
Recent Results
- Figure 4-9: Roche Diagnostics Revenue by Product Group, Full Year Results, 2020, 2021, CHF MN
- Figure 4-10: Roche COVID-19 Testing by Segment (PCR, Antigen & Serology), Quarterly Reports, 2020 and 2021
Siemens Healthineers
- Table 4-10: Siemens Healthineers Corporate Summary
Recent Results
- Figure 4-11: Siemens Diagnostics Revenue, FY 2020 and FY 2021, € MN
Thermo Fisher Scientific
- Table 4-11: Thermo Fisher Scientific Corporate Summary
Recent Results
- Figure 4-12: Thermo Fisher Scientific COVID-19 Response Revenue, 2020 and 2021 by Quarter
COVID-19 Test Providers
- Table 4-12: Test Companies with an EUA-Issued COVID-19 Test (Company, Location, Test Product, Date EUA)
Related products
In Vitro Diagnostic (IVD) Procedure Volumes, 2023-2028
October 22, 2023
Gain invaluable insights into the global IVD market with Kalorama Information’s comprehensive report In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028. This analysis provides essential data on the number of IVD procedures, offering a gold standard for new entrants and existing marketers in the diagnostic products industry.
Â
…
$6,000.00 – $9,000.00
In Vitro Diagnostic (IVD) Trends and Market Update: March 2024
March 26, 2024
Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.
The report offers updated data analysis based on Kalorama Information’s annual…
$5,000.00 – $7,875.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
$5,000.00 – $7,875.00
